Determining Respiratory Impairment in Connective Tissue Disease-Associated Interstitial Lung Disease

被引：8

作者：

Assayag, Deborah ^{[1
]}

Ryerson, Christopher J. ^{[2
]}

机构：

[1] McGill Univ, Dept Med, Montreal, PQ H3T 1E2, Canada

[2] Univ British Columbia, St Pauls Hosp, Dept Med, Vancouver, BC V6Z 1Y6, Canada

来源：

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2015年 / 41卷 / 02期

关键词：

Connective tissue disease; Interstitial lung disease; Respiratory impairment; Pulmonary function testing; Diagnosis; IDIOPATHIC PULMONARY-FIBROSIS; 6-MINUTE WALK DISTANCE; SURFACTANT PROTEIN D; RHEUMATOID-ARTHRITIS; SYSTEMIC-SCLEROSIS; MORTALITY; PNEUMONIA; PROGRESSION; PREDICTORS; CT;

D O I：

10.1016/j.rdc.2014.12.003

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Connective tissue diseases (CTDs) can affect the lungs through diseases of the chest wall, pleura, vasculature, airways, and parenchyma. Interstitial lung disease (ILD) is a common complication of CTD associated with increased morbidity and mortality. This article describes the evaluation of respiratory impairment in patients with CTD and summarizes the evidence that guides diagnosis and management of CTD-ILD. Patients with CTD with suspected ILD should undergo clinical, physiologic, and radiologic studies to evaluate for the presence of ILD, and these results should be integrated in a multidisciplinary setting to guide diagnosis and management. Screening for ILD may also be appropriate in asymptomatic patients with high-risk features.

引用

页码：213 / +

页数：13

共 43 条

[1]

Arai S, 2013, MOD RHEUMATOL, V23, P872, DOI [10.1007/s10165-012-0756-0, 10.3109/s10165-012-0756-0]

[2] Distinguishing Pulmonary Hypertension in Interstitial Lung Disease by Ventilation and Perfusion Defects Measured by Cardiopulmonary Exercise Testing [J].